The Patent Finder

Kalypsys, Inc.

Also on record
Records under this name other than the patents Kalypsys, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Kalypsys, Inc.

PatentTitleStatus Expires Confidence
US 7,517,884Sulfonyl-substituted bicyclic compounds as modulators of PPAR
Term ended
Term ended Sep 6, 2026 · From the USPTO record
Term endedTerm ended Sep 6, 2026From the USPTO record
US 7,834,004Sulfonyl-substituted bicyclic compounds as modulators of PPAR
Term ended
Term ended Feb 14, 2026 · From the USPTO record
Term endedTerm ended Feb 14, 2026From the USPTO record
US 7,915,253Sulfonyl-substituted bicyclic compounds as modulators of PPAR
Term ended
Term ended Feb 14, 2026 · From the USPTO record
Term endedTerm ended Feb 14, 2026From the USPTO record
US 7,494,999Sulfonyl-substituted bicyclic compounds as modulators of PPAR
Term ended
Term ended Jan 11, 2026 · From the USPTO record
Term endedTerm ended Jan 11, 2026From the USPTO record
US 9,463,189Sulfonyl-substituted bicyclic compounds as PPAR modulators for the treatment of non-alcoholic steatohepatitis
Formerly held
Lapsed on the fee record
Ended Oct 11, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 11, 2024From the USPTO record
US 8,859,550Heterocyclic inhibitors of histamine receptors for the treatment of disease
Lapsed on the fee record
Ended Oct 14, 2022 · From the USPTO record
Lapsed on the fee recordEnded Oct 14, 2022From the USPTO record
US 8,569,300Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of disease
Lapsed on the fee record
Ended Oct 29, 2021 · From the USPTO record
Lapsed on the fee recordEnded Oct 29, 2021From the USPTO record
US 9,078,887Bicyclic Heteroaryl Inhibitors of PDE4
Formerly held
Lapsed on the fee record
Ended Jul 14, 2019 · High confidence
Lapsed on the fee recordEnded Jul 14, 2019High confidence
US 8,258,154Bicyclic Heteroaryl Inhibitors of PDE4
Formerly held
Lapsed on the fee record
Ended Sep 4, 2016 · High confidence
Lapsed on the fee recordEnded Sep 4, 2016High confidence
US 8,138,205Heteroarylalkoxy-substituted quinolone inhibitors of PDE4
Lapsed on the fee record
Ended Mar 20, 2016 · From the USPTO record
Lapsed on the fee recordEnded Mar 20, 2016From the USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited